Navigation Links
A Perfect Storm Threatens Patient Access to Specialty Medical Care
Date:6/17/2008

- Unless Congress acts before the end of the month, declining reimbursement rates may force physicians to discontinue specialty services, leaving

patients with limited access to care when they need it most -

WARSAW, Ind., June 17 /PRNewswire/ -- As baby boomers approach retirement age, a confluence of forces may threaten access to the specialty care they need to treat their bone and joint disorders.

A near-epidemic level of bone and joint disorders is rapidly approaching, according to One Patient, an advocacy initiative recently launched by Biomet, Inc. a manufacturer of medical devices in Warsaw, Ind. At the same time, experts predict a shortage of physicians in general, and bone and joint specialists in particular. This shortage is likely to be worsened by declining reimbursement, which discourages physicians from focusing on specialty treatment such as joint replacement surgery for bone and joint disease.

Among the most common joint diseases, arthritis affects approximately 47 million Americans, including 50 percent of Americans over age 65. That figure is expected to grow to 67 million by 2030, according to the National Center for Health Statistics. Worse, arthritis and other bone and joint diseases are among the most expensive medical disorders: loss of earnings from disability resulting from them totaled $339 billion in 2004.

Now, as the need for specialty treatment mounts, at least three independent sources project physician shortages in the United States of between 55,000 and 200,000 by 2020. In particular, the supply of orthopaedic surgeons, specialists in treating bone and joint disorders, has grown at an average yearly rate of only 1.1 percent per 100,000 citizens for the last 10 years. To meet projected demand, the supply of orthopaedic surgeons must grow 23- 54 percent by 2020, according to the Health Resources and Services Administration.

"Patients who need total joint replacements and the surgeons who perform those procedures will be particularly hard hit," said Richard Iorio, M.D., an orthopaedic surgeon from Burlington, Mass. who has studied supply and demand issues of joint replacement surgery.

Total joint replacement involves the removal of painful arthritic joints that are replaced with high-tech implants. Approximately one million total joint replacements are performed annually in the United States, according to industry analyst reports.

Total hip and total knee replacement surgeries are prime examples. Demand for total hip replacement is expected to grow 174 percent while the demand for total knee replacement surgery is expected to grow 673 percent by 2030. Yet, of the 92 fellowship programs in the United States to train surgeons in total joint replacement, 38 percent went unfilled in 2007-08, Iorio said. Iorio attributes the shortfall to declining Medicare reimbursement policies.

"Since 1992, Medicare has cut surgeon reimbursement for joint replacement by at least 42 percent and there is no end in sight," Iorio said. "Medicare plans on cutting an additional 10.6 percent in July, followed by 5 percent in January 2009, and a total of 40 percent by 2016, and yet physician practice expenses are expected to grow over 20 percent in that time frame."

The reimbursement cuts will affect all doctors; nearly seven in 10 members surveyed by the American Medical Association said they will be forced to respond to the scheduled July cuts by either restricting Medicare treatment or discontinuing it altogether.

Congress is now working on versions of legislation which would forestall the cuts in the near term. However, Iorio says a long-term solution is needed. For more information, or to send a letter to legislators in support of preserving access to specialty care, patients, physicians and clinicians should visit http://www.onepatient.us.

"Certainly we support a short-term measure but Medicare needs to work with the legislature to come up with a long-term solution, or it will face a shortage of trained specialists. The best and brightest will not be attracted to medicine if Medicare and other reimbursement organizations pay at rates that do not allow physicians to even cover their costs. And worse, the most vulnerable segment of our population, the elderly, who are especially hard-hit by bone and joint disease, will be hurt the most," Iorio said.

About One Patient

One Patient is an advocacy initiative of Biomet, Inc. Launched in May of 2008, its mission is to advocate for ongoing patient access to specialty care and for rational reimbursement policies which affect that access.


'/>"/>
SOURCE Biomet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Novel gate dielectric materials: perfection is not enough
2. Pure Plastics Pitch Proves Perfect
3. A Scientist Dechipers the Code to Beautiful, Healthy Skin in The New Science of Perfect Skin
4. Perfecting a solar cell by adding imperfections
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
9. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
10. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
11. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016  Vermillion, Inc. (NASDAQ: VRML ), ... announced the formation of the Steering Committee for its ... --> Pelvic masses can present physicians and ... Once pregnancy is ruled out, pelvic masses may include ... endometriosis, benign ovarian tumors and gastrointestinal and urinary tract ...
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling ... (CSO) that provides biopharma companies the experience, expertise, ... and deploy outsourced sales teams. Created in concert ... addresses both the strategic and tactical needs of ... sales solutions through both personal and non-personal promotion. ...
(Date:2/11/2016)... Feb. 11, 2016  Dovetail Genomics™ LLC today announced ... program for a planned metagenomic genome assembly service. ... metagenomic genome assembly method in a talk on Friday, ... & Technology conference in Orlando, Fla. ... complex datasets is difficult. Using its proprietary ...
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, which has created ... pursue the highest level of accuracy and quality with the addition of two ... AR5 Refractometer. Accurate, reliable and tough enough for the most demanding applications, ...
Breaking Biology Technology:
(Date:1/18/2016)... Jan. 18, 2016  Extenua Inc., a pioneering ... the use and access of ubiquitous on-premise and ... with American Cyber.  ... leading transformational C4ISR and Cyber initiatives in support ... latest proven technology solutions," said Steve Visconti ...
(Date:1/13/2016)... , January 13, 2016 ... published a new market report titled - Biometric Sensors Market ... Forecast, 2015 - 2023. According to the report, the global biometric ... is anticipated to reach US$1,625.8 mn by 2023, expanding ... In terms of volume, the biometric sensors market is ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):